Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification

BACKGROUND: Increasing knowledge about the genomic changes underpinning cancer development and growth has led to a rapidly expanding number of individualized therapies that specifically target these changes in a patient's tumor. Here we present a case report of a patient with metastatic esophag...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Hempel, Dirk, Wieland, Thomas, Solfrank, Beate, Grossmann, Vera, Steinhard, Johanna, Frick, Andrea, Hempel, Louisa, Eberl, Thomas, Gaumann, Andreas
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Precision Medicine Clinic: Molecular Tumor Board
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288663/
https://ncbi.nlm.nih.gov/pubmed/32323889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0641
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items